Market News How it works Learn FAQ
| RCT 0.132 73.46% | NU 12.36 -18.47% | EWZ 33.885 -20.44% | TGL 0.254 14.67% | SRTM 0.326 -24.24% | BBD 2.855 -29.85% | ITUB 7.6 -21.41% | AZTR 1.615 125.87% | SHFS 0.103 -22.21% | XP 15.575 -48.78% | GCDT 0.1361 -22.71% | CLRO 4.79 47.38% | SOXL 91.64 9.67% | SPCX 149.92 1.65% | NWGL 0.0829 1.10% | PBR 21.94 -16.13% | NVD 3.99 -4.77% | SGRY 23.0703 46.48% | TSLL 10.9599 12.29% | VALE 11.99 -3.31% | RBNE 0.1701 -10.47% | CRWV 57.4626 5.95% | INTC 90.785 4.40% | NVDA 216.2072 2.49% | SOXS 47.41 -9.63% | BITO 10.77 -0.55% | ABEV 2.8 -15.15% | IREN 26.5486 6.60% | JBLU 2.295 -12.57% | NOK 8.625 5.96% | XTND 2.2 24.29% | SPRC 1.5001 37.62% | GPUS 0.1782 5.51% | TQQQ 69.14 4.30% | SBS 4.765 -25.55% | INTR 4.6286 -35.62% | TSLG 5.48 12.53% | RWM 14.435 -0.79% | TSLA 395.443 6.24% | SPDN 8.475 -0.76% | SQQQ 37.975 -4.30% | AAL 12.2055 0.79% | SID 0.9269 -21.45% | GGB 4.765 -6.57% | PBR-A 19.3388 -17.81% | RENT 2.9015 26.15% | LUCD 0.5155 25.43% | CIFR 8.1475 2.61% | KORU 10.9537 3.53% | WULF 12.08 6.71%
TTTitan Pharmaceuticals, Inc. logo

Titan Pharmaceuticals, Inc. (TTNP)

NASDAQ Capital Market · Currency in USD
$2.34 ▼ -0.30 (-11.36%)
As of Dec 16, 1:46 PM ET. Market open.

Summary

Previous Close
$2.64
Open
$2.55
Day's Range
$2.30 – $2.69
52 Week Range
$2.33 – $15.15
Volume
131,904
Avg. Volume
98,584
Market Cap
$3.11M
Beta (5Y Monthly)
1.38
PE Ratio (TTM)
--
EPS (TTM)
-$1,922.00
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Titan Pharmaceuticals, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
4
CEO
Weei Jye Chay

Titan Pharmaceuticals, Inc. is a pharmaceutical company dedicated to creating treatments for chronic conditions, with its product development centered around ProNeura, a unique platform designed for extended drug release. Currently, the company markets the Probuphine implant in Canada and the European Union. This implant provides maintenance treatment for clinically stable individuals struggling with opioid use disorder.

Earnings

DateEst.Actual
Jan 1, 2026–-$0.57
Aug 14, 2025–-$0.65
May 14, 2025–-$0.62
Mar 20, 2025–-$0.85
Jan 3, 2025–-$0.83
Aug 15, 2024–-$2.29

Analyst view

Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on TTNP and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.